Hidekazu Tsukamoto Selected Research

Liver Neoplasms (Liver Cancer)

11/2018	Baicalein Targets GTPase-Mediated Autophagy to Eliminate Liver Tumor-Initiating Stem Cell-Like Cells Resistant to mTORC1 Inhibition.
1/2018	The 2-oxoglutarate carrier promotes liver cancer by sustaining mitochondrial GSH despite cholesterol loading.
3/2016	The role of IL-17 signaling in regulation of the liver-brain axis and intestinal permeability in Alcoholic Liver Disease.
3/2010	Changes in the expression of methionine adenosyltransferase genes and S-adenosylmethionine homeostasis during hepatic stellate cell activation.
8/2009	S-adenosylmethionine in the chemoprevention and treatment of hepatocellular carcinoma in a rat model.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hidekazu Tsukamoto Research Topics

Disease

24	Neoplasms (Cancer) 02/2024 - 02/2009
16	Alcoholic Liver Diseases (Alcoholic Liver Disease) 04/2020 - 02/2002
14	Liver Cirrhosis (Hepatic Cirrhosis) 01/2023 - 05/2004
14	Liver Diseases (Liver Disease) 01/2023 - 02/2002
12	Fibrosis (Cirrhosis) 04/2020 - 10/2005
10	Tics (Tic) 02/2024 - 07/2013
10	Inflammation (Inflammations) 01/2024 - 01/2004
9	Carcinogenesis 10/2023 - 02/2009
7	Fatty Liver 01/2023 - 08/2011
7	Hepatocellular Carcinoma (Hepatoma) 11/2020 - 08/2009
7	Alcoholic Fatty Liver 01/2017 - 09/2008
7	Obesity 01/2016 - 10/2005
5	Alcoholic Hepatitis 01/2024 - 10/2016
5	Liver Neoplasms (Liver Cancer) 11/2018 - 08/2009
3	Alcoholism (Alcohol Abuse) 01/2020 - 03/2012
3	Pancreatitis 01/2020 - 01/2008
3	Hypoxia (Hypoxemia) 01/2018 - 10/2009
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2017 - 01/2016
2	Non-alcoholic Fatty Liver Disease 01/2017 - 01/2016
2	Endotoxemia 01/2016 - 02/2009
2	Insulin Resistance 01/2016 - 10/2005
2	Hepatitis 01/2015 - 08/2007
2	Hyperhomocysteinemia 09/2011 - 07/2002
2	Melanoma (Melanoma, Malignant) 07/2011 - 10/2010
2	Hemochromatosis (Bronze Diabetes) 09/2008 - 02/2004
1	Acute Liver Failure (Fulminant Hepatic Failure) 01/2024
1	Vascular Remodeling 01/2023
1	End Stage Liver Disease 01/2022
1	Cicatrix (Scar) 04/2020
1	Brain Injuries (Brain Injury) 01/2020

Drug/Important Bio-Agent (IBA)

11	Ethanol (Ethyl Alcohol)IBA 01/2023 - 10/2009
9	Proteins (Proteins, Gene)FDA Link 02/2024 - 02/2009
6	NF-kappa B (NF-kB)IBA 01/2020 - 10/2002
5	MicroRNAs (MicroRNA)IBA 01/2023 - 09/2012
5	CytokinesIBA 01/2022 - 01/2018
5	Messenger RNA (mRNA)IBA 02/2015 - 06/2003
5	IronIBA 02/2015 - 06/2003
4	RNA (Ribonucleic Acid)IBA 01/2023 - 01/2020
4	Interleukin-17 (Interleukin 17)IBA 01/2020 - 03/2016
4	Methionine (L-Methionine)FDA Link 06/2014 - 07/2002
4	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 08/2005 - 02/2002
3	Histones (Histone)IBA 03/2023 - 08/2015
3	ChemokinesIBA 01/2022 - 01/2015
3	CeruletideIBA 01/2020 - 01/2008
3	Biomarkers (Surrogate Marker)IBA 01/2020 - 07/2014
3	CholesterolIBA 01/2020 - 01/2018
3	Small Interfering RNA (siRNA)IBA 01/2018 - 02/2009
3	Diethylnitrosamine (N-Nitrosodiethylamine)IBA 03/2016 - 03/2012
3	necdinIBA 09/2015 - 10/2010
3	EndotoxinsIBA 04/2015 - 07/2013
2	ChromatinIBA 02/2024 - 10/2009
2	Oncogene Proteins (Oncogene Protein)IBA 02/2024 - 01/2015
2	Transcription Factors (Transcription Factor)IBA 07/2023 - 01/2012
2	CateninsIBA 01/2023 - 01/2017
2	NitrosaminesIBA 11/2020 - 01/2017
2	Stearoyl-CoA DesaturaseIBA 01/2020 - 01/2017
2	Epithelial Cell Adhesion MoleculeIBA 01/2020 - 01/2015
2	AcetaldehydeIBA 01/2018 - 01/2017
2	Liposomes (Liposome)IBA 01/2018 - 01/2017
2	3-deazaneplanocinIBA 01/2017 - 02/2010
2	Carbon Tetrachloride (Tetrachloromethane)IBA 06/2012 - 02/2010
2	LeptinIBA 01/2012 - 03/2010
2	Toll-Like Receptor 4IBA 08/2011 - 02/2009
2	AntigensIBA 07/2011 - 10/2010
2	S-Adenosylmethionine (Ademetionine)IBA 03/2010 - 08/2009
2	metal transporting protein 1 (ferroportin)IBA 11/2008 - 02/2004
2	Transferrin (beta 2 Transferrin)IBA 09/2008 - 02/2004
2	PPAR gammaIBA 12/2005 - 05/2004
1	Protect-ItIBA 02/2024
1	UbiquitinIBA 02/2024
1	Biliverdine (Biliverdin)IBA 01/2024
1	CLOCK ProteinsIBA 10/2023
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2023
1	AcidsIBA 01/2023
1	Sirtuin 1IBA 01/2023
1	Leukotriene B4 Receptors (Leukotriene B4 Receptor)IBA 01/2023
1	OxylipinsIBA 01/2023
1	Conditioned Culture MediaIBA 01/2023
1	stearoyl-coenzyme A (stearoyl-CoA)IBA 01/2023
1	LigandsIBA 01/2023
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2022
1	Acetates (Acetic Acid Esters)FDA Link 01/2022
1	AC133 AntigenIBA 11/2020
1	Collagen Type I (Type I Collagen)IBA 04/2020
1	Extracellular Matrix ProteinsIBA 04/2020
1	S100 Calcium Binding Protein A6IBA 01/2020
1	LipopolysaccharidesIBA 01/2020
1	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 01/2020
1	nephronectinIBA 01/2020
1	IntegrinsIBA 01/2020
1	Nicotine FDA Link 01/2020
1	fibroblast growth factor 21IBA 01/2020
1	Interleukin-6 (Interleukin 6)IBA 01/2020
1	Interleukin-17 ReceptorsIBA 01/2020
1	GTP Phosphohydrolases (GTPases)IBA 11/2018
1	Mechanistic Target of Rapamycin Complex 1IBA 11/2018

Therapy/Procedure

4	Therapeutics 10/2023 - 10/2016
3	Liver Transplantation 01/2024 - 10/2006
3	Drug Therapy (Chemotherapy) 11/2018 - 03/2012
2	Ligation 01/2023 - 01/2017